ࡱ> }U ! "#CD%&'()*+,-./0123456789:;<=>?@ABEGFHV^JKLMNOPQRST|WXYZ[\]jk`abcdefghimlnopqrtsuwvxyz{~Root Entry_ FKG__nameid_version1.0( `9.GF1G__substg1.0_00020102*__substg1.0_00030102*x *-.14589<>BFGHKLMOUVW[`abcdefghijklmnopqrstuvwxyz{|}~Pc ̜_ FAAZk 3z.B{yᩎTk?@0GZ+##]h2GULN3Fo:0FJZx0 d    x    < x  DP  ( < \  ,d !,"#$,%X&'( )P *t + , -T . / 0 1 2 3 4< 5l 6 7 8\ 9 :;\<=>0?@A BPCDE FHGhH I J K( LMNۚE ?C Ixja)!(46@/l#89% Fp + 槥 0&u%*H__substg1.0_00040102*__substg1.0_10000102* __substg1.0_10010102* __substg1.0_10020102* ,BigFunnelCorrelationId0ExchangeApplicationFlagsHasQuotedText&IsQuotedTextChanged.LastIndexingAttemptTime,HeaderBodyFragmentList^X-MS-Exchange-Organization-ATPSafeLinks-MsgData2CurrentMessageSafetyFlags NetworkMessageId$IsPartiallyIndexed<BigFunnelCompleteIndexingStart8BigFunnelCompleteIndexingEnd DetectedLanguage6ConversationIndexTrackingEx$ClassificationType>OriginalInferenceClassificationHGriffinInferenceClassificationResult:InferenceClassificationResultBGriffinTriageHeuristicsFeatureSet4TriageHeuristicsFeatureSet.EntityExtraction/Url1.0>EntityExtraction/EmbeddedUrl1.0,ClassificationLastScan,LatestMessageWordCountIsSignedIsReadReceiptJX-Microsoft-Antispam-Mailbox-DeliveryBX-Microsoft-Antispam-Message-Info4InferenceMessageIdentifier2ConversationContributions,ConversationWasFocusedJx-ms-exchange-organization-authsourceBx-ms-exchange-organization-authasdx-ms-exchange-organization-originalclientipaddressdx-ms-exchange-organization-originalserveripaddress,x-ms-publictraffictype&ClassificationCount0ClassificationConfidence@ComposedClassificationAttributesFDetailedClassificationSchemeEnabled.ClassificationContextV2 IsExternalSenderFEntityExtraction/ExtractLanguage1.0NEntityExtraction/KeyPhraseExtraction2.0:InferenceClassificationReasonBInferenceClassificationTrackingExDarwin/Url2.0,FocusedInboxModelScorereceived-spfrX-MS-Exchange-Organization-ATPSafeLinks-UrlContainer-Data|X-MS-Exchange-Organization-ATPSafeLinks-UrlContainer-Signature6x-forefront-antispam-report,authentication-results4x-ms-traffictypediagnosticZx-ms-exchange-crosstenant-originalarrivaltimeTx-ms-exchange-crosstenant-fromentityheader8x-ms-exchange-crosstenant-idbx-ms-exchange-transport-crosstenantheadersstampedXx-ms-exchange-crosstenant-network-message-idNx-ms-exchange-transport-endtoendlatencyNx-ms-office365-filtering-correlation-id(x-microsoft-antispamNx-ms-exchange-processed-by-bccfolderingHx-ms-exchange-crosstenant-authsource@x-ms-exchange-crosstenant-authas8AntispamSafeLinksWrappedUrlsDx-ms-exchange-atpmessageproperties,x-eopattributedmessage8x-eoptenantattributedmessage@AntispamSafelinksIsIntraOrgEmailBodyLanguages&AttachmentLanguagesDX-MS-Exchange-Organization-BUABFLC,EntityExtraction/IsM2HFIFeatureSetVEntityExtraction/KPEM2HItemProcessorSuccess__substg1.0_10030102*(__substg1.0_10040102*__substg1.0_10050102*__substg1.0_10060102* D&әVX Lͼ^3)E1 3! 2 D6C7,B *DGS ')' a J-?l __substg1.0_10070102*__substg1.0_10080102* __substg1.0_100C0102*__substg1.0_100D0102*__substg1.0_100E0102*__substg1.0_100F0102* __substg1.0_10100102*__substg1.0_10110102* Z,##Դ:j Jڱ+?KD d7 %h ,jG  uK V$j59 buTQK>zihA bEF a(%ѽS/d ߻c= Q M__substg1.0_10120102* __substg1.0_10130102*(__substg1.0_10140102*__substg1.0_10150102*__substg1.0_10160102*__substg1.0_10170102* __substg1.0_10180102*!__substg1.0_10190102*"b. h.N -V (l(~b65 ™4 yz  +}=2I 'u%0y;?v BNC"P<__substg1.0_101A0102*#__substg1.0_101B0102*$__substg1.0_101C0102*% __substg1.0_101D0102* &__substg1.0_101E0102*'__substg1.0_001A001F*"(__substg1.0_0037001F*)~__substg1.0_003B0102*!%+IPM.NoteIRAS Project ID 316755. HRA and HCRW Approval for the AmendmentSMTP:NOREPLY@HARP.ORG.UKܧ@B+//O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISSIS, Resource__substg1.0_003D001F*__substg1.0_003F0102*$&,__substg1.0_0040001F*/__substg1.0_00410102*#+0v+nTamendments@hra.nhs.ukSMTPnoreply@harp.org.ukamendments@hra.nhs.ukܧ@B+//O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISSIS, Resource~z+nTamendments@hra__substg1.0_0042001F*2*__substg1.0_00430102*(*3__substg1.0_0044001F*6__substg1.0_004F0102*)-7.nhs.ukSMTPamendments@hra.nhs.ukamendments@hra.nhs.ukEX:/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISEX:/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISSMTP__substg1.0_0050001F*:*__substg1.0_00510102*,.;|__substg1.0_00520102*=|__substg1.0_0064001F*'7?__substg1.0_0065001F*@&__substg1.0_0070001F*02A~__substg1.0_00710102*C__substg1.0_0075001F*15Dnoreply@harp.org.ukIRAS Project ID 316755. HRA and HCRW Approval for the Amendment.&QjMlSK_EX/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F__substg1.0_0076001F*E__substg1.0_0077001F*46I__substg1.0_0078001F*J__substg1.0_007D001F*3;$<495C875F5632DDE22D7C-SISEX/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SIS+nTamendments@hra.nhs.ukSMTPnoreply@harp.org.ukReceived: from PAXPR01MB8883.eurprd01.prod.exchangelabs.com (2603:10a6:102:2bb::15) by DB7PR01MB4396.eurprd01.prod.exchangelabs.com with HTTPS; Mon, 28 Jul 2025 09:40:46 +0000 Received: from DU2PR04CA0308.eurprd04.prod.outlook.com (2603:10a6:10:2b5::13) by PAXPR01MB8883.eurprd01.prod.exchangelabs.com (2603:10a6:102:2bb::15) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8989.11; Mon, 28 Jul 2025 09:40:42 +0000 Received: from DU6PEPF0000A7DF.eurprd02.prod.outlook.com (2603:10a6:10:2b5:cafe::f0) by DU2PR04CA0308.outlook.office365.com (2603:10a6:10:2b5::13) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.8964.26 via Frontend Transport; Mon, 28 Jul 2025 09:40:42 +0000 Authentication-Results: spf=pass (sender IP is 5.101.140.163) smtp.mailfrom=harp.org.uk; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=harp.org.uk;compauth=pass reason=100 Received-SPF: Pass (protection.outlook.com: domain of harp.org.uk designates 5.101.140.163 as permitted sender) receiver=protection.outlook.com; client-ip=5.101.140.163; helo=cpanel.harp.org.uk; pr=C Received: from cpanel.harp.org.uk (5.101.140.163) by DU6PEPF0000A7DF.mail.protection.outlook.com (10.167.8.36) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8989.10 via Frontend Transport; Mon, 28 Jul 2025 09:40:42 +0000 Received: from map191734-fw-089255.hea021.cpe.exponential-e.net ([178.22.160.68]:51914 helo=HRA-HARPAPP02) by cpanel.harp.org.uk with esmtpa (Exim 4.98.1) (envelope-from <noreply@harp.org.uk>) id 1ugKLZ-000000007bu-3Hxl; Mon, 28 Jul 2025 10:40:41 +0100 MIME-Version: 1.0 From: "amendments@hra.nhs.uk" <noreply@harp.org.uk> To: mark.wilson19@nhs.net, k.boland@imperial.ac.uk, k.boland@imperial.ac.uk, SIS@warwick.ac.uk Reply-To: amendments@hra.nhs.uk Date: 28 Jul 2025 10:40:41 +0100 Subject: IRAS Project ID 316755. HRA and HCRW Approval for the Amendment Content-Type: text/html; charset=utf-8 Content-Transfer-Encoding: base64 X-AntiAbuse: This header was added to track abuse, please include it with any abuse report X-AntiAbuse: Primary Hostname - cpanel.harp.org.uk X-AntiAbuse: Original Domain - warwick.ac.uk X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12] X-AntiAbuse: Sender Address Domain - harp.org.uk X-Get-Message-Sender-Via: cpanel.harp.org.uk: authenticated_id: noreply@harp.org.uk X-Authenticated-Sender: cpanel.harp.org.uk: noreply@harp.org.uk X-Source: X-Source-Args: X-Source-Dir: Message-ID: <1286bd65-af85-484a-a974-e646481243bb@DU6PEPF0000A7DF.eurprd02.prod.outlook.com> Return-Path: noreply@harp.org.uk X-MS-Exchange-Organization-ExpirationStartTime: 28 Jul 2025 09:40:42.0853 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: cb1df0e4-2211-43e8-8e00-08ddcdbad19d X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 09bacfbd-47ef-4465-9265-3546f2eaf6bc:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: DU6PEPF0000A7DF:EE_|PAXPR01MB8883:EE_|DB7PR01MB4396:EE_ X-MS-Exchange-Organization-AuthSource: DU6PEPF0000A7DF.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: cb1df0e4-2211-43e8-8e00-08ddcdbad19d X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:3;ARA:13230040|3072899012|2092899012|12012899012|8096899003|13003099007; X-Forefront-Antispam-Report: CIP:5.101.140.163;CTRY:GB;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:cpanel.harp.org.uk;PTR:cpanel.harp.org.uk;CAT:NONE;SFS:(13230040)(3072899012)(2092899012)(12012899012)(8096899003)(13003099007);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 28 Jul 2025 09:40:42.0174 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: cb1df0e4-2211-43e8-8e00-08ddcdbad19d X-MS-Exchange-CrossTenant-Id: 09bacfbd-47ef-4465-9265-3546f2eaf6bc X-MS-Exchange-CrossTenant-AuthSource: DU6PEPF0000A7DF.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAXPR01MB8883 X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.4490967 X-MS-Exchange-Processed-By-BccFoldering: 15.20.8922.036 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(930097)(140003)(1420198); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?wKKIZqHsUz9BN2aqTDeQ5XbXACuOqSwvVNiJhh48CTlZPA+28H+3kzE3CuE3?= =?us-ascii?Q?Xc9USTtjBRMFp4bIeEmLK5R7798MRHK6zHmCtX8ns5Shnp7tOvwrhBWnjuxy?= =?us-ascii?Q?TNspECM4Z//+KeccszGpjQ8+A7gJPTgk+HXHhb29fbq0MB4Gf2DkqlkAER1V?= =?us-ascii?Q?zybry7argnwEJ+CAqioRQ2KD3wJ45t8qrkc3GQftyiHDwMMcew8OBOnQqz1J?= =?us-ascii?Q?Izs2B5ZhU5AyYGZwt2HmN8KbFSDeR81knK29qNPn7WYAH4js9mlG7d5VLsWA?= =?us-ascii?Q?uBC9dloDuxv3jOtfKzkAz+4Pytnyfky+jU8n5p19OycEiPjvKIX2oCc3pKCz?= =?us-ascii?Q?VizVUVUOCUubQ4CdyWC0yjGk66LuCgM39OT9LdV1PJwvqWMd5eID4NAPICBr?= =?us-ascii?Q?lJ6ELEU5Pu/yYovL9o4hn2ma5ZFZBPVGxfZ6OEzyRVNhc/AF2ovHg8rTcHM1?= =?us-ascii?Q?hpUScC66kKWYrF7srL3EzkU6Ogs/8yMz94MfMfMHoAr90VC0dcUbg1gwh3Fv?= =?us-ascii?Q?inReqwHLcAqLQ3am754LRJLMLN62NKf8XB1uMhrHfHKFSliqDhtdYabVFPYm?= =?us-ascii?Q?/P9ggJhWyBii32TJFH3EfHb8o/3K5IZ38y3SWCKoblkKhaVup3SUqJBkrsFY?= =?us-ascii?Q?zgQYqBUdo+RZuJMln/Fq6CJpGPjM/9AavZsmQ3CyxUnIMWtEUzE2jkCXWIUa?= =?us-ascii?Q?XYV7pRrKE4/3T4bxexm1q0FJ6aAMF4kNWk5GNPUSBw8EosJIQoL/y85xswCV?= =?us-ascii?Q?R2ETDtZuBdWVUWS5ltrhb+tFxfC8zo9UVApLvpCrRp7LDK1ExQT7SJsv7NWq?= =?us-ascii?Q?RLwkKAWOPihWuQqJw4H08vlaPu9DYQfqCwRiBM3ZQC8uLzgMre1WZO792teI?= =?us-ascii?Q?KVZu3AnPyfAWzODP9QIOb5GBraEwM9jxy+HgFGBGoEvYpzn29fY2SAuNE2bM?= =?us-ascii?Q?SOtELiagVpxDnGyt/SvSfWePTLKroP9AWV6lu645t0hDwU0z33eydaX5qWDE?= =?us-ascii?Q?4C88OJ64/grVxLQhaOc5WGZ7tjRmqNTM1qTIsX8Il1EyDwaIoajdTWQXmW4i?= =?us-ascii?Q?8XV2XaTb1ly6luQLaBE1oLWeKuQ7zhPJWyWUC+5ywQ/qMglvXD+khPSw18ty?= =?us-ascii?Q?jc0LPiquA5p73HDAFW/swsneAbeVp7a+wXrEb0W1FCPnfXSdDMGkiAEfEn3P?= =?us-ascii?Q?KkBKqoRLR8YouC4+OMvJK9CFG3mcUP9ooQswa6Q8Y+F7X3F66dxOcx08r3/M?= =?us-ascii?Q?IhzXya6kaJKZLs1PS0gY02G4igox0ICikV+RxfvrxunfgqcG2Rw97+TjTVXN?= =?us-ascii?Q?qi0Il9C4oyt/6x9OIZTsSZfl2SJZInurc7lhoBPK3shRkJE15D9AIBtpTIjQ?= =?us-ascii?Q?gWtoA2rTorkZAZoaYUDl2QuWWgABdBlnfiZNa46mA1hdMrV8xpMJ01cRGznT?= =?us-ascii?Q?YbHxuQ7LoRhzXbC7usNgHfvsZPzjgrn6N2tefHEKUz69zxpBNoSAvK3ptB5E?= =?us-ascii?Q?Y3UBNAcJUDgi65waujVEqDmuXcEBtdUjH/W7OhEWNj7rKNqSC53tV7j5PLEr?= =?us-ascii?Q?YEyhWQSPoCbPAGlYHa6YG35THFn0hL3nZ181W8vtdJ1v+L5g6OTX0a+AWI66?= =?us-ascii?Q?Y9O6JrKBElq3g/O0vHao+TYgMizRiWpyo4lL7DFxX2IwMBilwJtgPprB4Alb?= =?us-ascii?Q?TW73Efa0vjLiylqU/VlMwXi1clXIZL9ZnDpgkihyQPqvpe/lTbl1xsJvH8wf?= =?us-ascii?Q?edd2Q3riN7Tt4X48vlZ0TzW3VgmFxHUsERUlXDvit/zufACZA0pfZ3ilo76o?= =?us-ascii?Q?sNBpTqt3E3qcFuezix8QnqcwypUYKHpwhx5Bm2ybprttRdup6jh+6OeakRjk?= =?us-ascii?Q?3/1ggEG8aO9xYl3ZihJcdttLrv5TzBJ8Y3fNIhn8mouf3u+aw1QiQw/Ew+e6?= =?us-ascii?Q?BsLxwvF7EAEd34xDGZTnfpjL/paaTY1aEGYbsGk2mV8rdad7QhA0OX1pVPIb?= =?us-ascii?Q?NV5tvLJ4lonPIQA0Tn4XvLWg0qH6gAUPmeCbqGRUP3DVUH0fCgvqZODJw/fX?= =?us-ascii?Q?gSOsHLwMFjh9Q+BgYZbjLSHFqrTALlgm66lZCVElj+wv49Fl+PQ+aegQNBwT?= =?us-ascii?Q?VKVKKVqKakYg5Ya4a8fKhn+osNG5g5vh5vTmUWrl94rQ9QRQ+ltQn/LQuVVy?= =?us-ascii?Q?dwzq4OTIRpuyFJcyid/qRNY/6cpeabTG/lW+/UFZFHFlAiXi0/jo9Y3KCk2e?= =?us-ascii?Q?wIe3/031cNwLexkNieePiKbzENNDkJthv6VZZX2KRo3rrBEHjNAEsuJ/N6YT?= =?us-ascii?Q?c28=3D?= __substg1.0_0C190102*Nv__substg1.0_0C1A001F*8:P*__substg1.0_0C1D0102*Q__substg1.0_0C1E001F*9=Ramendments@hra.nhs.ukSMTP:NOREPLY@HARP.ORG.UKSMTPnoreply@harp.org.ukWILSON, Mark (IMPERIAL COLLEGE HEALTHCARE NHS TRUST); k.boland@imperial.ac.uk; k.boland@imperial.ac.uk; SIS, Resource__substg1.0_0C1F001F*S&__substg1.0_0E02001F*<>__substg1.0_0E03001F*__substg1.0_0E04001F*/OT__substg1.0_0E05001F*X __substg1.0_0E0B0102*@BY.__substg1.0_0E1D001F*Z~__substg1.0_0E4C0102*AE\SA003f͛/Z {.qhLƳA?"!|IRAS Project ID 316755. HRA and HCRW Approval for the AmendmentRMj7q8Q[@5k,.&QjMlSK_M4LZFu/3Ua fbidccpg1252Rhtml1 ch set0 __substg1.0_0E590102*]__substg1.0_0F030102*DF^__substg1.0_1000001F*I__substg1.0_10090102*CK_Dear Prof Wilson, IRAS Project ID: 316755 Short Study Title: Spinal Immobilisation Study (SIS) Amendment No./Sponsor Ref: Substantial Amendment 3 Amendment Date: 24 June 2025 Amendment Type: Substantial Non-CTIMP I am pleased to confirm HRA and HCRW Approval for the above referenced amendment. You should implement this amendment at NHS organisations in England and Wales, in line with the guidance in the amendment tool. User Feedback The Health Research Authority is continually striving to provide a high quality service to all applicants and sponsors. You are invited to give your view of the service you have received and the application procedure. If you wish to make your views known please use the feedback form available on the HRA website: http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/<https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.hra.nhs.uk%2Fabout-the-hra%2Fgovernance%2Fquality-assurance%2F&data=05%7C02%7CSIS%40warwick.ac.uk%7Ccb1df0e4221143e88e0008ddcdbad19d%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638892924466035765%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=kGpNERjJL1NbhL4kSCy0F3X5eyuXbBB0QSJeW32UpoE%3D&reserved=0>. Please contact amendments@hra.nhs.uk<https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Famendments%40hra.nhs.uk%2F&data=05%7C02%7CSIS%40warwick.ac.uk%7Ccb1df0e4221143e88e0008ddcdbad19d%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638892924466056830%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=YzQuXr8E2CMM1ALrr7m9NMfE91FGaNKdCexcn0fu%2BU8%3D&reserved=0> for any queries relating to the assessment of this amendment. Kind regards Syeda Thorpe Health Research Authority 2nd Floor | 2 Redman Place | Stratford | London | E20 1JQ E.amendments@hra.nhs.uk<mailto:amendments@hra.nhs.uk> W. www.hra.nhs.uk<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2F&data=05%7C02%7CSIS%40warwick.ac.uk%7Ccb1df0e4221143e88e0008ddcdbad19d%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638892924466073502%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=z8laYXbO3Cc9su4WOtrtAQd5rNrSTTnSbbbbhGAU%2Ft4%3D&reserved=0> Sign up to receive our newsletter HRA Latest<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2Fabout-us%2Fhra-latest%2F&data=05%7C02%7CSIS%40warwick.ac.uk%7Ccb1df0e4221143e88e0008ddcdbad19d%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638892924466097016%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=yOFuw5xsEBeEPWOtGqu9C9kaf3kCjT0LAQSZfTHdRkg%3D&reserved=0> mP2ý2 } ; b19 _ 2s 5 843K9%p* atP`so Ex1nRvrtPnt  d R I\vwk d5"@0 r!Rbkmks BM_BEGIN}$Fp8g64&<"!tp-equiv=" !0-Tyxpe"!2*")!xt/"3!0D=W#*o#-"(tit#>SE56 P(App`v@)0'9.Tem Q}! /@ p !2fi ` HRA .Uw!a# 2!tB* -4"tr9a(p>&  f$W\957 ҳ&F D(P`f ,ln,'/P<$U&/(B ?$(B-p;"3dth7a5cm+4#55R - `^pp5H7dax-mc43GFCMH_IkL)1-R3<E J275`-R!FL50%GhQJ)e#c!OJ( `%@U;O%@` Ax Xw 00,@ZBbps ;rhJMx4428[88. 2sb\0@ Vw= 0>I0?jUq`D:@}SXB(brAx=4bD_( '2DAz[fERSWC3>31670cAefghij2Rn]EYtPOQ_klTUVWb/YPZ?P[O\_oO^?"Sh tu32aOc?r_e_tuvw?kmnop 1qIm` 4`si (SIS)r/O_oy_zo{|}~ρYZoߛ?"A2&o.@p R_?OϚ/?Ǽub%A01)3_¿ߧO_o_ϰY3ZD/O_oo۟ȏɟʯ>24 Ju5!ο/?O_o܏ݟޢ0/Y Z 濹*r /O?˿1qn-CTIMP. Lgus 4?O_o-O-EO;]O>?` xam 6?pM 0toMn Q9p 7{8H`09P >CRW pp v <8 faFF E?F rN 09`.CF@ P2 "{2/5G$56J4L6B9YouPul 0im9C EX9PH`P`g̀UyQ E`R!EA?Wes,W* D( ̀ WD:olEF_GoNI]K;P/Q?=O8fU9лpFe P`ck@;_\_OOabRO9TD!H9;0/Y09# cY0Au ``U:Anul`;ivm~g:? D1` qrqes Y:rw9P?ćU?s$sES# Zs A:gsySps ewV0fDuy`aD xWDv?E!y0eEIyz S:makxUkn2|9 (uqD!DeC9pzmpm`4aV0Z4>wePxA:t!Dttp s://ey001.D*kw`? @; 0.S [@k.:@m/?y0l=@%3A%2Fw .a.nhw`\ukDQq`-D-agDqrEt-sy0&R=n%7Cp%40w# f .fҍcb1dme143epe08ddcePd19d9ffb7659r2359f6bc“63pВВ607UPTWFpbGZl3d@yJFbXBU1hcGkiOnRydWepIlYA iIwLjqPM@DAwMCIAJXaW4zMkFOIjo&isdU1yf:QD4&sSkGpNERjJL1NbhL4kSCy0F3XB50uXbBQSJeW32U E&Du Q0 qxlsqaU,/;/8// )<yp{T:fTm >YPpLINK /?O_oϒߓ/?O_o)T p;088cT8ߨfMAg0n_8./Ao*+i.'jK?lM_kn8]Pr"f考߯os߷/?H83oŸïĿYzQ`r8E2CMM1AL7m9NMfE91FGa`dCexcn0fuPBU8=@ fVPet_#& k/?O_o/?O_o9ORHOB>qtDUDrQsSD X@sUyU [\_^1o?23)K:@{DV`9U?L7?O_/8a"9`XryP氍 rVPb(0X`G255);F#"PfH`9?:O?%wSyt pV@pefNFaCD>?;?@AfⲹչG841))%3DZڴڰ屫鰿S尪}2 SE56 (Approval) Template email to confirm HRA Approval for an amendment

ý

Dear Prof Wilson,

IRAS Project ID:
316755
Short ý Title:
Spinal Immobilisation ý (SIS)
Amendment No./Sponsor Ref:
Substantial Amendment 3
Amendment Date:
24 June 2025
Amendment Type:
Substantial Non-CTIMP

I am pleased to confirm HRA and HCRW Approval for the above referenced amendment.    

You should implement this amendment at NHS organisations in England and Wales, in line with the guidance in the amendment tool.

User Feedback

The Health Research Authority is continually striving to provide a high quality service to all applicants and sponsors. You are invited to give your view of the service you have received and the application procedure. If you wish to make your views known please use the feedback form available on the HRA website: .

Please contact for any queries relating to the assessment of this amendment.

Kind regards

Syeda Thorpe
Health Research Authority
2nd Floor | 2 Redman Place | Stratford  | London | E20 1JQ
E.amendments@hra.nhs.uk
W.

Sign up to receive our newsletter


rod.outlook.com>#G`F65K.&QjMlSK_k  KQW +13579;=GISUY]'-?"B?@@??*%)ACE2/:B[amendments@hra.nhs.uk__substg1.0_300B0102*__substg1.0_30130102*LN__substg1.0_30140102* __substg1.0_36770102*GWQ__substg1.0_3FF8001F**__substg1.0_3FF90102*PRv__substg1.0_3FFA001F*__substg1.0_3FFB0102*QU+nTamendments@hra.nhs.ukSMTPnoreply@harp.org.ukSIS, Resourceܧ@B+//O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISSMTPnoreply@harp.org.uk__substg1.0_4022001F*__substg1.0_4023001F*TV&__substg1.0_4024001F*__substg1.0_4025001F*S[EX/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISamendments@hra.nhs.ukamendments@hra.nhs.ukDA0F5B4CA90F495C875F5632DDE22D7C__substg1.0_4030001F**__substg1.0_4031001F*XZ*__substg1.0_4034001F*H__substg1.0_4035001F*Y]H-SISDA0F5B4CA90F495C875F5632DDE22D7C-SISamendments@hra.nhs.ukSIS, ResourceLJee2PtW0Kbe+iLJFxhhzg==noreply@harp.org.uknoreply@harp.org.uk__substg1.0_4038001F**__substg1.0_4039001F*\^__substg1.0_50CF0102*__substg1.0_5D01001F*?&__substg1.0_5D02001F*&__substg1.0_5D07001F*`b"__substg1.0_5D08001F*"__substg1.0_5D0A001F*ae&SIS@warwick.ac.ukSIS@warwick.ac.uknoreply@harp.org.ukSIS@warwick.ac.ukϺ GeDe5F{.qhLƳA?"!|{.qhLƳA?"ۓi{.qhLƳA?" O__substg1.0_5D0B001F*"__substg1.0_5D160102*df__substg1.0_65E00102*__substg1.0_65E10102*ck__substg1.0_65E20102*__substg1.0_65E30102*hj__substg1.0_70970102* __substg1.0_80000048*im{.qhLƳA?" OcY%gކG2Fi*}P-+ dtD.ȊM eyJJc1VybEJlaW5nU2Nhbm5lZCI6IiIsIlVybFdyaXRlVGltZSI6IjcvMjgvMjAyNSA5OjQwOjQ2IEFNIiwiQVNEaXJlY3Rpb25hbGl0eSI6IjEiLCJQaGlzaEVkdSI6__substg1.0_80060102*"__substg1.0_8007001F*lnX__substg1.0_80090048*__substg1.0_800D001F*gwIjAiLCJNc2dTY2FuU3VzcGljaW9uTGV2ZWwiOiIwIn0="CͺѝenBT=0;II=<invalid>;TFR=ThreadForkingIsDisabled;Version=Version 15.20 (Build 8922.0), Stage=H12;UP=10;DP=1;QT=9;CPBT=__substg1.0_800E001F*__substg1.0_800F101F*pr __substg1.0_80130102* __substg1.0_80140102*qu JJJFocusedInboxFeatureSet_50104B??? ? ??@@ !"#$%&'(?)*+?,-./1A2345678BE      !"#$%&'(*+.789:;<>?@ABCDEFGHIJMNOPQRSTUVWXYZ[\]_`abcdghijknopqrsuvwxy{FGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~?? D@@@SD\B> #=Q>Q>u?k> ף<@C{@)\? #<k>= W>Q8> ?k> #<<u>H:?=(\?`A)\>@= W>? ? Q>   ?)\=)\== W>@? )\>!Q?"#$%&@5D'= 7@(@)Y?*+,>-<./Qx?0 #<12)\=3)\>456 ף>789:;<=>{.>?Qx?@ ף=A)\>B ף>CDEFGa>G ף #=Q>Q>u?k> ף<@C{@)\? #<k>= W>Q8> ?k> #<<u>H:?=(\?`A)\>@= W>? ? Q>   ?)\=)\== W>@? )\>!Q?"#$%&@5D'= 7@(@)Y?*+,>-<./Qx?0 #<12)\=3)\>456 ף>789:;<=>{.>?Qx?@ ף=A)\>B ף>CDEFGa>G ףm]>.&I'':ߏ W&Nfy)]*iQ\R(h3\f矐~ryL9 rUg\%dJU)G\&*m B!?_2&[ { "@type": "ExtractLanguage", "@context": "http://schema.microsoft.com", "@outputVersion": "1.0", "@source": "Bling", "BlingDetectorType": "ExternalWithHints", "TextLength": 1146, "LanguageScores": { "English": 100.0 }, "Language": { "Locale": "en-US", "name": "English (United States)", "BestGuessLanguage": "en", "@type": "Language" } } ]FocusedSenderByRatioBCAT=BulkDueToWellKnownSenderLocalPatterns;DNRT=Microsoft.Exchange.FocusedInbox.Models.Heuristics.DoNotReplyFeaturizer+DoNotRepl[ { "@outputVersion": "2.0", "@formatter": "TeeKpeBondCbpBase64", "@schema": "Microsoft.Exchange.Relevance.TeeKpeBondResponse.TeeKpe.TeeKpeResponse", "@correlationTrail": "AssetId=b2d4ddb6-5089-4047-bdc5-16ef646c7eb1;ExtractionId=c55e914b-8e93-44ad-bb59-c2c46fdd60ba;EntityId=2fee4491-482f-41b2-9269-4cab525d2c88", "keyPhrases": "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", "@type": "KeyPhraseExtraction", "@context": "http://schema.microsoft.com", "@EntityId": "2fee4491-482f-41b2-9269-4cab525d2c88", "@extractionTimeUtc": "2025-07-28T09:40:48.0136544Z" } ]__substg1.0_802D001F*K(__substg1.0_802E001F*LB__substg1.0_802F001F*^__substg1.0_8030001F*eyTypes;SCAT=None;RFV=1032232302:-1=8^-1927059262:-1=0^1146315108:-1=0^1810071250:sender-41640920-3557-4593-b9e7-8bae903e321b=0^1352796317:recipient-670d461d-1029-4aa3-94d0-234e7ace653b=1537^1352796317:recipient-c3f71b6d-bc2a-41e5-97b2-0d6624237b80=1025^1352796317:recipient-f73bd3ce-3fb0-4a22-96d9-c868420e9316=1665^;SV=1.0.784.0;SN=DB9PR01MB9031;MV=5010;CT=7/28/2025 9:40:46 AM;ODF=Inbox;IFIC=<null>;HDTR=0;HDTF=V154[{"EntityId":"fb4cb3ef-756f-4414-a560-1f16a5d7f51a","RankingContext":{"Features":[{"Name":"MachineLearningRanker","Value":0.67297363}],"FeaturesMap":{"MachineLearningRanker":0.67297363},"RelevanceScore":0.0}}]0.5265896Pass (protection.outlook.com: domain of harp.org.uk designates 5__substg1.0_8031001F*fr__substg1.0_8032001F*__substg1.0_8033001F*l__substg1.0_8034001F*m.101.140.163 as permitted sender) receiver=protection.outlook.com; client-ip=5.101.140.163; helo=cpanel.harp.org.uk; pr=C--DEPRECATED--CIP:5.101.140.163;CTRY:GB;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:cpanel.harp.org.uk;PTR:cpanel.harp.org.uk;CAT:NONE;SFS:(13230040)(3072899012)(2092899012)(12012899012)(8096899003)(13003099007);DIR:INB;spf=pass (sender IP is 5.101.140.163) smtp.mailfrom=harp.org.uk; dkim=none (message not signed) header.d=none;dmarc=pass action=__substg1.0_8035001F*tj__substg1.0_8036001F*zn__substg1.0_8037001F*|>__substg1.0_8038001F*}none header.from=harp.org.uk;compauth=pass reason=100DU6PEPF0000A7DF:EE_|PAXPR01MB8883:EE_|DB7PR01MB4396:EE_28 Jul 2025 09:40:42.0174 (UTC)Internet09bacfbd-47ef-4465-9265-3546f2eaf6bc__substg1.0_8039001F*~H__substg1.0_803A001F*__substg1.0_803B001F*H__substg1.0_803C001F* PAXPR01MB8883cb1df0e4-2211-43e8-8e00-08ddcdbad19d00:00:04.4490967cb1df0e4-2211-43e8-8e00-08ddcdbad19dBCL:3;ARA:13230040|3072899012|2092899012|12012899012|8096899003|__substg1.0_803D001F*H__substg1.0_803E001F*__substg1.0_803F001F*__substg1.0_8040001F*R13003099007;15.20.8922.036DU6PEPF0000A7DF.eurprd02.prod.outlook.comAnonymousSA|SL009bacfbd-47ef-4465-9265-3546f2ea__substg1.0_8041001F*__substg1.0_8043001F* __substg1.0_8044001F*__substg1.0_8045001F*Lf6bc:01;en1;0=100;1=0;2=0;3=1;4=0;5=1;6=0;7=0;8=1;9=0;10=0;11=1;12=0;13=0;14=0;15=0;16=0;17=0;18=0;20=1;25=1;27=0;28=3;29=0;30=0;31=0;32=0;33=0;34=0;35=0;36=0;37=0;38=0;39=__substg1.0_8047001F*__substg1.0_8048001F*__substg1.0_804B001F*8__substg1.0_804D001F*60;40=1;41=0;42=0;43=1;44=0;45=0;46=0;47=0;49=8;50=0;51=0;52=0;53=0;54=0;55=0;56=0;66=0;69=0;70=0;71=0;72=0;73=0;74=0;75=0;76=0;77=0;78=0;79=0;80=0;81=0;82=0;83=0;84=0;85=0;86=0;87=0;88=0;89=0;90=0;91=0;92=0;93=0;94=0;95=0;96=0;97=0;98=0;99=0;100=0;101=0;102=0;103=0;104=0;105=0;106=0;107=0;108=0;109=0;110=0;111=0;112=0;113=0;114=0;115=0;116=0;117=0;118=0;119=0;120=0;121=0;122=0;123=0;124=0;125=0;126=0;127=0;128=0;129=0;130=0;131=0;132=0;133=0;134=0;135=0;136=0;137=0;138=0;139=0;140=0;141=0;142=0;143=0;144=0;145=0;146=0;147=0;148=0;149=0;150=0;151=0;152=0;153=0;154=0;155=0;156=0;157=0;158=0;193=1;194=1;195=2025;196=7;197=6;198=0;199=0;200=0;201=845;202=0.19;203=0.04;204=0;205=0.36;206=0.36;207=0.96;208=0;209=0;210=0.23;211=0.02;212=192;213=0;214=0;215=2.47;216=0;217=0.56;218=0.01;219=0;220=0;221=0;222=0;223=0;224=0.23;225=0.21;226=0.18;227=0.55;228=0;229=0;230=0;231=0;232=0.23;233=0;234=0;235=0.01;236=0;237=0;238=0;239=0.03;240=0;241=0;242=0;243=0;244=0;245=0;246=0.24;247=0.73;248=0.1;249=0.86;250=0;251=0;252=14;253=0.14;254=0;255=2;256=0;257=0.21;258=0;259=0;260=0;261=0;262=0;263=0;264=0.5;265=0.5;266=0.36;267=0;268=0;269=0;270=0;271=0;272=0.5;273=0;274=0;275=0;276=0;277=0;278=0.07;279=0.07;280=0;281=0;282=0;283=0;284=0;285=0;286=0.21;287=0.75;288=0.14;289=0.82;290=0;291=0;292=0;293=0;294=725;295=2.86;296=6;297=0.85;298=0;299=0;300=0.15;301=0.03;302=0;303=0.97;304=0.01;305=0;306=0.07;307=0.28;308=0;309=0;310=0.32;311=0;312=0;313=0;314=0;315=0;316=0;317=0;318=0.17;319=0.97;320=0.08;321=0.28;322=0.32;323=0;324=0;325=0;326=0.22;327=0.02;328=2.03;329=1.36;330=0;331=2.85;332=0.78;333=0;334=1.72;335=2.3;336=0;337=0;338=2.37;339=0;340=0;341=0;342=0;343=0;344=0;345=0;346=2.1;347=2.85;348=1.75;349=2.3;350=2.37;351=0;352=0;353=0;354=2.2;355=1.11;356=0;357=3;358=0;359=0Christina.May@warwick.ac.uk00000002/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=bb1efab5980d40e1865a13871d4a85c0-u2173714@0G@0G 4y__substg1.0_804E001F* __properties_version1.00` __recip_version1.0_#00000000:>G >G__substg1.0_0C240102* !"#$%()+,45789:=>@AIJLMNOTUWX\]^`efhijlmnoprtv .x{e{H U6?67= E6@IUep 0q-{ 'h1 b Zz ?5b I< @  ֱ@&r?z{"ѹ{B,e(Ave{;{](d @9򀮣v@ , (   vл{]( 0{ )ZOȾ{ X Y WH @DP,&?3{C{Q|m{R|{uvwx}<   g{ #/L{Y{ @IU  {0{0 {[3^3@3&rZ6c6'h6 w6Q{ 6? ?,?v{?{"@ #@($@%@0@,1@,4@J5@J8@,9@Z@7PPo{]$]$ ]( ]$]C{e]{e{{e{p { @ &r@ 6   { {l@<  H  T!"#$ %&'8 (){ *+f,?-*.D/01t2345l6p7@89J:;J<"=J>?@TA BC DEN FG HI JK: Ls{ 5{M8N8Q[@5k,wojOtUhܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448cܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448cWILSON, Mark (IMPERIAL COLLEGE H__substg1.0_0C2C0102* __substg1.0_0FF60102* __substg1.0_0FF90102* }__substg1.0_0FFF0102* }__substg1.0_3001001F*h__substg1.0_3002001F*__substg1.0_3003001F*__substg1.0_300B0102*dEALTHCARE NHS TRUST)EX/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448cEX:/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=USER7137448Cmark.wilson19@nhs.net__substg1.0_39FE001F**__substg1.0_3A20001F*h__substg1.0_5FE5001F*__substg1.0_5FF70102*}WILSON, Mark (IMPERIAL COLLEGE HEALTHCARE NHS TRUST) ܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448c/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448c__substg1.0_66CA001F*__properties_version1.00 h__recip_version1.0_#00000001: >G0>G__substg1.0_0FF60102*&0j00@Lt }xz 0dp :j  @:}|z_}gz9$ t, ӏz9@9,__f0+nTk.boland@imperial.ac__substg1.0_0FF90102*'__substg1.0_0FFF0102**__substg1.0_3001001F*-.__substg1.0_3002001F*..ukSMTPk.boland@imperial.ac.uk+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.ukk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.uk__substg1.0_3003001F*/.__substg1.0_300B0102*0__substg1.0_39FE001F*1.__substg1.0_3A20001F*2.SMTP:K.BOLAND@IMPERIAL.AC.UKk.boland@imperial.ac.ukk.boland@imperial.ac.uk+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.uk000 00`Lt 0`z 0`t :__substg1.0_5FF70102*3__properties_version1.006__recip_version1.0_#00000002:0>GpKG__substg1.0_0FF60102*;0  @:<{_{990_0+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.uk+nTk.boland@imperial.ac__substg1.0_0FF90102*<__substg1.0_0FFF0102*?__substg1.0_3001001F*B.__substg1.0_3002001F*C.ukSMTPk.boland@imperial.ac.ukk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.ukSMTP:K.BOLAND@IMPERIAL.AC.UKk.boland@imperial.ac.ukk.boland@imperial.ac.uk__substg1.0_3003001F*D.__substg1.0_300B0102*E__substg1.0_39FE001F*F.__substg1.0_3A20001F*G.    __substg1.0_5FF70102*H__properties_version1.00K__recip_version1.0_#00000003:pKGKG__substg1.0_0C240102*P+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.uk000 00Lt 0`z 0t :0  @:9 {_ {990_08Q[@5k,)#9DԍWQFܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sisܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c__substg1.0_0C2C0102*Q__substg1.0_0FF60102*R__substg1.0_0FF90102*S__substg1.0_0FFF0102*V875f5632dde22d7c-sisSIS, ResourceEX/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sisEX:/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23S__substg1.0_3001001F*Y__substg1.0_3002001F*Z__substg1.0_3003001F*[__substg1.0_300B0102*_|PDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISSIS@warwick.ac.ukSIS, Resourcesip:sis@live.warwick.ac.ukܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sis/o=ExchangeLabs/ou=Exchange Admi__substg1.0_39FE001F*a"__substg1.0_3A20001F*b__substg1.0_5FE5001F*c4__substg1.0_5FF70102*d__substg1.0_66CA001F*g__properties_version1.00kh__substg1.0_800F101F-00000000<qJ__substg1.0_800F101F-00000001<sJnistrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sis000Lt pst 0|0`z :  @:pUst_st9$ `t, ʏz9@9$_6_f050b8b56b-4ef8-44c2-a924-03374f5831ce321c43ef-82f4-4b68-be93-179f54b42dab065bdd91-ef07-40d3-b8a4-0aea722eaa49__substg1.0_800F101F-00000002<uJ